| Mar 20 2025 |
Patent Trial and Appeal Board Designates “Informative” Decision Regarding Claim Construction |
K&L Gates LLP |
| Mar 20 2025 |
No Bull: Historically Generic Term Can Become Non-Generic |
McDermott Will & Schulte LLP |
| Mar 20 2025 |
Power Play: Pull the Plug on Parallel District Court Litigation, ITC Investigation |
McDermott Will & Schulte LLP |
| Mar 20 2025 |
Get a Grip: Not All Cords Have Handles |
McDermott Will & Schulte LLP |
| Mar 20 2025 |
Palette of Evidence: PTAB Must Consider Entire Record to Determine Prior Art Status |
McDermott Will & Schulte LLP |
| Mar 20 2025 |
Construing Unambiguous Claim Language and Qualifying Challenged Expert as POSITA |
McDermott Will & Schulte LLP |
| Mar 20 2025 |
“Regulations of the State Council on the Settlement of Foreign-Related Intellectual Property Disputes” Unveils Countermeasures Against Those That Use IP Disputes as an Excuse “to Contain and Suppress China” |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 19 2025 |
Design Patent Obviousness |
Womble Bond Dickinson (US) LLP |
| Mar 19 2025 |
UK-Based Graffiti Artists Sue Vivienne Westwood in California for Misuse of Their Tags |
Katten |
| Mar 19 2025 |
How the Lashify Decision Could Expand IP Enforcement Strategies at the ITC to Protect U.S. Domestic Industry |
Womble Bond Dickinson (US) LLP |
| Mar 19 2025 |
DC Circuit Affirms Decision That Copyright Statute Requires Some Amount of Human Authorship, Leaves More Difficult Questions for Another Day |
Bradley Arant Boult Cummings LLP |
| Mar 19 2025 |
China’s National Development and Reform Commission: High-Value Invention Patents per 10,000 People Reached 14 |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 18 2025 |
China Remains Top Source of Patent Cooperation Treaty (PCT) Applications in 2024 |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 18 2025 |
Federal Circuit Touches on Appellate Standing and Prior Art Determinations in the Context of Post-Grant Review Proceedings |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 17 2025 |
Delaying Examination of Continuing Applications Could Sabotage USPTO Goals |
Foley & Lardner LLP |
| Mar 17 2025 |
Make Protecting Your UK and EU Product Packaging and Labels Your New Year’s IP Resolution. Part 2: Combatting Dupes and Copycats in the United Kingdom |
K&L Gates LLP |
| Mar 14 2025 |
5-Year Prison Term for Counterfeiting Burberry in China |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 14 2025 |
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 |
Polsinelli PC |
| Mar 14 2025 |
Chinese Court Again Rules AI-Generated Images Are Eligible for Copyright Protection |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 13 2025 |
USPTO’s Rescission of its Discretionary Denial Memorandum – Much Ado About Nothing? |
Womble Bond Dickinson (US) LLP |
| Mar 13 2025 |
Federal Circuit Clarifies Anticipation Analysis for Product-By-Process Claims |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 13 2025 |
Artists Protest AI Copyright Proposal in the U.K. |
Robinson & Cole LLP |
| Mar 13 2025 |
An Odyssey of Timeliness: Appointments Clause Arguments Must Be Preserved |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
Validity Analysis for Product-by-Process Claim Focuses on Product |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
PTO Reverts to Prior Post-Grant Guidelines for Cases Involving Parallel District Court Litigation |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
Inventor’s Motivation to Combine Does Not Control Obviousness |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
Economic Prong of Domestic Industry Requirement Includes All Sorts of Labor and Capital |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
Interesting Delay: Prejudgment Interest Accrues Despite Unreasonable Delay |
McDermott Will & Schulte LLP |
| Mar 13 2025 |
Impact of the USPTO’s Rescission of its Discretionary Denial Memorandum |
Womble Bond Dickinson (US) LLP |
| Mar 12 2025 |
Federal Circuit Affirms ImmunoGen Patent Obviousness |
ArentFox Schiff LLP |
| Mar 12 2025 |
Federal Circuit Refuses to Extend IPR Estoppel to Unadjudicated Patent Claims |
ArentFox Schiff LLP |
| Mar 12 2025 |
Limits on Physician Noncompete Agreements: Navigating New State Laws and Legislation |
Epstein Becker & Green, P.C. |
| Mar 12 2025 |
Federal Circuit Expands Scope of Activities That Can Establish a ‘Domestic Industry’ Under Section 337 |
ArentFox Schiff LLP |
| Mar 12 2025 |
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs |
Foley & Lardner LLP |
| Mar 11 2025 |
Dewberry Group, Inc. v. Dewberry Engineers Inc. (No. 23-900) |
Wiggin and Dana LLP |
